Dividends

The Ensign Group, Inc. (ENSG) Ex-Dividend Date Scheduled for September 29, 2020

The Ensign Group, Inc. (ENSG) will begin trading ex-dividend on September 29, 2020. A cash dividend payment of $0.05 per share is scheduled to be paid on October 31, 2020. Shareholders who purchased ENSG prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 4th quarter that ENSG has paid the same dividend. At the current stock price of $55.93, the dividend yield is .36%.

The previous trading day's last sale of ENSG was $55.93, representing a -7.32% decrease from the 52 week high of $60.35 and a 132.46% increase over the 52 week low of $24.06.

ENSG is a part of the Health Care sector, which includes companies such as HCA Healthcare, Inc. (HCA) and Universal Health Services, Inc. (UHS). ENSG's current earnings per share, an indicator of a company's profitability, is $2.43. Zacks Investment Research reports ENSG's forecasted earnings growth in 2020 as 38.44%, compared to an industry average of -1.1%.

For more information on the declaration, record and payment dates, visit the ENSG Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to ENSG through an Exchange Traded Fund [ETF]?
The following ETF(s) have ENSG as a top-10 holding:

  • Invesco S&P SmallCap Health Care ETF (PSCH)
  • First Trust Small Cap US Equity Select ETF (RNSC)
  • The Long-Term Care ETF (OLD)
  • Inspire Small/Mid Cap Impact ETF (ISMD)
  • ProShares Trust (SMDV).

The top-performing ETF of this group is OLD with an increase of 20.05% over the last 100 days. PSCH has the highest percent weighting of ENSG at 3.21%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ENSG

NASDAQ.com

Nasdaq

Get the latest stock market news, stock information & quotes, data analysis reports, as well as a general overview of the market landscape from Nasdaq.

Read Nasdaq.com's Bio